ORGO
Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) has 11 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 25, 2026.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Gary S. Gillheeney
- Employees:869
- HQ:Canton, MA, US
- IPO:2017-01-05
Insider Buying
$40K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$344.8M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Leibowitz Arthur SFirst filing | Director | Purchase | 5,000 | $13K | Mar 11 | SEC ↗ |
Driscoll Michael JosephFirst filing | Director | Purchase | 10,000 | $27K | Mar 11 | SEC ↗ |
Related companies
Organogenesis Holdings Inc. is in the Healthcare sector.